As of 2026-03-31, the Relative Valuation of CVS Health Corp (CVS) is 26.70 USD. This relative valuation is based on P/E multiples. With the latest stock price at 70.14 USD, the upside of CVS Health Corp based on Relative Valuation is -61.9%.
The range of the Relative Valuation is 20.51 - 31.96 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.9x - 23.0x | 21.0x |
| Forward P/E multiples | 15.5x - 20.3x | 18.3x |
| Fair Price | 20.51 - 31.96 | 26.70 |
| Upside | -70.8% - -54.4% | -61.9% |
| Date | P/E |
| 2026-03-30 | 50.47 |
| 2026-03-27 | 50.43 |
| 2026-03-26 | 51.22 |
| 2026-03-25 | 51.94 |
| 2026-03-24 | 52.39 |
| 2026-03-23 | 51.30 |
| 2026-03-20 | 51.44 |
| 2026-03-19 | 51.71 |
| 2026-03-18 | 52.54 |
| 2026-03-17 | 53.83 |
| 2026-03-16 | 54.57 |
| 2026-03-13 | 54.78 |
| 2026-03-12 | 54.74 |
| 2026-03-11 | 54.49 |
| 2026-03-10 | 54.92 |
| 2026-03-09 | 56.31 |
| 2026-03-06 | 56.07 |
| 2026-03-05 | 56.62 |
| 2026-03-04 | 57.98 |
| 2026-03-03 | 57.92 |
| 2026-03-02 | 58.76 |
| 2026-02-27 | 57.49 |
| 2026-02-26 | 56.13 |
| 2026-02-25 | 54.82 |
| 2026-02-24 | 53.38 |
| 2026-02-23 | 55.41 |
| 2026-02-20 | 55.18 |
| 2026-02-19 | 55.64 |
| 2026-02-18 | 55.95 |
| 2026-02-17 | 56.27 |
| 2026-02-13 | 56.47 |
| 2026-02-12 | 56.08 |
| 2026-02-11 | 55.42 |
| 2026-02-10 | 54.47 |
| 2026-02-09 | 54.52 |
| 2026-02-06 | 56.38 |
| 2026-02-05 | 54.93 |
| 2026-02-04 | 54.14 |
| 2026-02-03 | 55.29 |
| 2026-02-02 | 54.27 |
| 2026-01-30 | 53.62 |
| 2026-01-29 | 53.57 |
| 2026-01-28 | 53.27 |
| 2026-01-27 | 51.81 |
| 2026-01-26 | 60.35 |
| 2026-01-23 | 59.73 |
| 2026-01-22 | 59.49 |
| 2026-01-21 | 58.64 |
| 2026-01-20 | 57.63 |
| 2026-01-16 | 56.56 |